Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma

Overview of attention for article published in Cancer Cell International, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 3 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma

Cancer Cell International, 29 Dec 2022

Abstract Background Hyaluronic acid (HA) promotes cancer metastasis; however, the currently approved treatments do not target HA.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.